Physician profile
Abby E Meagher
NPI 1437673423
$562.79
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $342 · 2023: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $152.74 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.36 | 2022 | |
| Lilly USA, LLC | $40.65 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $36.00 | 2022 | |
| Amgen INC. | $33.30 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.36 | 2022-2023 | |
| Dexcom, INC. | $31.31 | 2023 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $23.96 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $20.19 | 2021 | |
| Ironwood Pharmaceuticals, INC | $19.02 | 2023 | Linzess |
| Antares Pharma, INC. | $16.29 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $16.05 | 2022 | |
| Bausch Health US, LLC | $15.78 | 2022 | |
| Acadia Pharmaceuticals INC | $15.43 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.20 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13.94 | 2022 | |
| Novo Nordisk INC | $13.77 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.93 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Meagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.